Clinical and epidemiological features of Chryseobacterium indologenes infections: Analysis of 215 cases
Authors:
- 1 December 2013
- journal article
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 46 (6) , 425-432
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Characterization of CIA-1, an Ambler Class A Extended-Spectrum β-Lactamase from Chryseobacterium indologenesAntimicrobial Agents and Chemotherapy, 2012
- Chryseobacterium indologenes bacteraemia in a preterm babyIndian Journal of Medical Microbiology, 2011
- Structure of metallo- -lactamase IND-7 from a Chryseobacterium indologenes clinical isolate at 1.65-A resolutionThe Journal of Biochemistry, 2010
- IND-6, a Highly Divergent IND-Type Metallo-β-Lactamase fromChryseobacterium indologenesStrain 597 Isolated in Burkina FasoAntimicrobial Agents and Chemotherapy, 2009
- Tigecycline and colistin susceptibility of Chryseobacterium meningosepticum isolated from blood in TaiwanInternational Journal of Antimicrobial Agents, 2009
- Identification and Characterization of a New Metallo-β-Lactamase, IND-5, from a Clinical Isolate of Chryseobacterium indologenesAntimicrobial Agents and Chemotherapy, 2007
- Chryseobacterium meningosepticum: An Emerging Pathogen Among Immunocompromised Adults Report of 6 Cases and Literature ReviewMedicine, 1997
- Flavobacterium indologenes Bacteremia: Clinical and Microbiological CharacteristicsClinical Infectious Diseases, 1996
- Topical antimicrobial prophylaxis of nosocomial pneumonia in mechanically ventilated patients. Microbiological observationsInfection, 1993
- Outbreak of nosocomial Flavobacterium meningosepticum respiratory infections associated with use of aerosolized polymyxin BAmerican Journal of Infection Control, 1989